Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for ibrutinib to a specific field?

Exact Matches

15
Related Substance Name

1
Display Name

1
Standardized Name

1
Code Literal

1
Any Name

1
LACTMED

1
WIKIPEDIA

Approximate Matches

19
Related Substance Name

16
Standardized Name

16
Any Name

12
Reference Text / Citation

4
Display Name

3
Note

2
Reference URL

1
Code Comments

1
Code Literal

1
LACTMED

1
Code URL

1
WIKIPEDIA

1
Relationship Comments

Showing 11 - 20 of 31 results

First page
Previous page
2
Next page
Next page

1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-methoxy-1-propanone

D5DT6Q8MDR

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethan-1-one, (R)-

BS3XHS4GTP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-chloro-1-propanone

NA99JX9VTS

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

3-(4-PHENOXYPHENYL)-1-(PIPERIDIN-3-YL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, (R)-

NR6GN4MC2R

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Conditions:

(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine is a chemical precursor of BTK inhibitor ibrutinib and related compounds. (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine lacks the propenamide group that is responsible for covalent binding to cysteine residue of BTK kinase.

IBRUTINIB, (S)-

Y6K7EN3Q6V

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1-PROPANONE, 1,3-BIS((3R)-3-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-1-PIPERIDINYL)-

ZPJ4HT8UNA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

PCI-45752

R89W1G0ITW

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

N-(2-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-5-HYDROXYPENTYL)-2,3-DIHYDROXYPROPANAMIDE, (R)-

YLV55WHI7Q

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

PCI-45741

31R6NGO9QR

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

PCI-45227

29446230GA

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

Structure of 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-methoxy-1-propanone

ABSOLUTE

1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-methoxy-1-propanone

Structure of 1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethan-1-one, (R)-

ABSOLUTE

1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)ethan-1-one, (R)-

Structure of 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-chloro-1-propanone

ABSOLUTE

1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-3-chloro-1-propanone

Structure of 3-(4-PHENOXYPHENYL)-1-(PIPERIDIN-3-YL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, (R)-

ABSOLUTE

3-(4-PHENOXYPHENYL)-1-(PIPERIDIN-3-YL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, (R)-

Structure of IBRUTINIB, (S)-

ABSOLUTE

IBRUTINIB, (S)-

Structure of 1-PROPANONE, 1,3-BIS((3R)-3-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-1-PIPERIDINYL)-

ABSOLUTE

1-PROPANONE, 1,3-BIS((3R)-3-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-1-PIPERIDINYL)-

Structure of PCI-45752

ABSOLUTE

Structure of N-(2-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-5-HYDROXYPENTYL)-2,3-DIHYDROXYPROPANAMIDE, (R)-

EPIMERIC

N-(2-(4-AMINO-3-(4-PHENOXYPHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)-5-HYDROXYPENTYL)-2,3-DIHYDROXYPROPANAMIDE, (R)-

Structure of PCI-45741

ABSOLUTE

Structure of PCI-45227

EPIMERIC

Showing 11 - 20 of 31 results

First page
Previous page
2
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1